Skip to main content
. 2009 Nov 16;27(36):6101–6108. doi: 10.1200/JCO.2009.22.2554

Fig 2.

Fig 2.

(A) Progression-free survival and (B) overall survival by intent-to-treat analysis. Patients were censored at the time of last follow-up without an event or at the time of coming off protocol treatment because of denial of insurance for autologous stem-cell transplantation (ASCT), patient refusal of ASCT, or allogeneic stem-cell transplantation. Dotted lines indicate 95% CIs.